News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
703,226 Results
Type
Article (41787)
Company Profile (464)
Press Release (660975)
Section
Business (209224)
Career Advice (2012)
Deals (36053)
Drug Delivery (93)
Drug Development (83412)
Employer Resources (170)
FDA (16371)
Job Trends (15224)
News (353271)
Policy (33042)
Tag
Academia (2626)
Alliances (50760)
Alzheimer's disease (1273)
Approvals (16295)
Artificial intelligence (139)
Bankruptcy (362)
Best Places to Work (11768)
Biotechnology (350)
Breast cancer (124)
Cancer (1123)
Cardiovascular disease (105)
Career advice (1680)
Cell therapy (250)
Clinical research (66072)
Collaboration (408)
Compensation (199)
COVID-19 (2595)
C-suite (100)
Data (1139)
Diabetes (158)
Diagnostics (6221)
Earnings (86106)
Employer resources (148)
Events (113064)
Executive appointments (317)
FDA (16919)
Funding (367)
Gene therapy (194)
GLP-1 (619)
Government (4424)
Healthcare (19068)
Infectious disease (2682)
Inflammatory bowel disease (114)
Interviews (310)
IPO (16599)
Job creations (3839)
Job search strategy (1436)
Layoffs (442)
Legal (7938)
Lung cancer (178)
Manufacturing (182)
Medical device (13374)
Medtech (13379)
Mergers & acquisitions (19518)
Metabolic disorders (434)
Neuroscience (1565)
NextGen Class of 2024 (6775)
Non-profit (4544)
Northern California (1499)
Obesity (250)
Opinion (199)
Patents (103)
People (57953)
Phase I (20711)
Phase II (29168)
Phase III (21572)
Pipeline (459)
Postmarket research (2590)
Preclinical (8892)
Radiopharmaceuticals (253)
Rare diseases (235)
Real estate (6228)
Regulatory (22000)
Research institute (2411)
Resumes & cover letters (352)
Southern California (1324)
Startups (3766)
United States (13901)
Vaccines (570)
Weight loss (189)
Date
Today (132)
Last 7 days (804)
Last 30 days (3889)
Last 365 days (36811)
2024 (33770)
2023 (41097)
2022 (52356)
2021 (56840)
2020 (55070)
2019 (47600)
2018 (35835)
2017 (33137)
2016 (32482)
2015 (38498)
2014 (32299)
2013 (27233)
2012 (29321)
2011 (29953)
2010 (28080)
Location
Africa (740)
Arizona (200)
Asia (38694)
Australia (6432)
California (3424)
Canada (1295)
China (253)
Colorado (149)
Connecticut (162)
Europe (84552)
Florida (462)
Georgia (116)
Illinois (357)
Indiana (199)
Kansas (100)
Maryland (592)
Massachusetts (2728)
Michigan (159)
Minnesota (278)
New Jersey (972)
New York (976)
North Carolina (763)
Northern California (1499)
Ohio (141)
Pennsylvania (852)
South America (1116)
Southern California (1324)
Texas (477)
Utah (92)
Washington State (374)
703,226 Results for "expansion therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
Inhibikase Therapeutics Announces Expansion to its Therapeutic Pipeline and Updates its Research and Development Programs
Inhibikase Therapeutics, Inc. today announced expansion of its therapeutic pipeline and multiple updates to its Research and Development programs.
June 5, 2024
·
6 min read
Pharm Country
Click Therapeutics Accelerates Expansion into Obesity and Cardiometabolic Disease With Acquisition of the Assets of Better Therapeutics, Inc.
Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ as prescription medical treatments, today announced plans to accelerate its development initiatives in obesity and cardiometabolic disease through the acquisition of the assets of Better Therapeutics, Inc.
May 22, 2024
·
7 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Press Releases
Bluejay Therapeutics Announces Expansion of Leadership Team and Board of Directors
November 21, 2024
·
4 min read
BioMidwest
DiaMedica Therapeutics Announces Expansion of DM199 (Rinvecalinase Alfa) Program Into Preeclampsia
DiaMedica Therapeutics Announces Expansion of DM199 (Rinvecalinase Alfa) Program Into Preeclampsia.
June 26, 2024
·
13 min read
Rakovina Therapeutics Announces Extensions and Expansions of Strategic Collaborations to Support AI Research
Rakovina Therapeutics Inc. is pleased to announce the expansion of two research collaborations to align with its recently announced collaboration with the Deep Docking AI Drug Discovery Platform.
May 8, 2024
·
6 min read
Biotech Beach
Kintara Therapeutics Announces Expansion of REM-001 Clinical Study to Include Patients on Pembrolizumab
Kintara Therapeutics, Inc. (Nasdaq: KTRA) (“Kintara” or the “Company”) today announced the expansion of the inclusion criteria in the open label 15- patient REM-001 study in cutaneous metastatic breast cancer (CMBC) to include patients receiving pembrolizumab (KEYTRUDA®) for at least three months at screening.
March 27, 2024
·
3 min read
Press Releases
Flashpoint Therapeutics Announces $50M KAIMRC Partnership and Clinical Pipeline Expansion
November 14, 2024
·
3 min read
Ajinomoto Co., Inc. Enhances StemFit iPS Cell Expansion Medium
Ajinomoto Co., Inc. launched a new version of its StemFit™ iPSC expansion medium.
March 26, 2024
·
3 min read
Genetown
Repare Therapeutics Doses First Patient in Camonsertib Monotherapy Non-Small Cell Lung Cancer Expansion of TRESR Clinical Trial
Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced the first patient has been dosed in the Company’s camonsertib monotherapy non-small cell lung cancer (NSCLC) expansion of the TRESR clinical trial.
June 10, 2024
·
5 min read
1 of 70,323
Next
